BETHLEHEM, Pa., Dec. 01, 2017 (GLOBE NEWSWIRE) -- B. Braun Medical Inc., a leader in customized parenteral nutrition, will showcase its Parenteral Nutrition 360 (PN360) program — designed to improve neonatal, pediatric and adult patient outcomes — at this year’s American Society of Health-System Pharmacists (ASHP) 52nd Midyear Clinical Meeting.
B. Braun is focused on unlocking precision through its customized parenteral nutrition product and service offerings. Parenteral nutrition needs can vary depending upon the patient’s age, body composition, clinical status and level of activity. Customized parenteral nutrition options provide an opportunity to create individualized nutrition that is as unique as the patient receiving it.
“Our PN360 program is a complete therapeutic approach to parenteral nutrition through our comprehensive offering of products, education, training and consultative services,” said Tom Sutton, Vice President of Solution Management at B. Braun.
“PN360 is a team approach to help meet any facility’s parenteral nutrition admixing needs,” he said. “The program is more than individual in-house compounding, parenteral nutrition solutions and outsourced compounded products or services. It’s an earnest collaboration with pharmacists, physicians, nurses and dietitians to tailor nutritional therapy for their most critical patients, as well as help reduce medical errors, infections and re-admissions.”
From Dec. 3-7 in the Orange County Convention Center, Orlando, FL, B. Braun representatives at booth #841 will showcase the company’s new macro and micro APEX® compounding system for facilities that need in-house compounding capabilities. Through its browser-based TPN Manager software, healthcare providers can enter parenteral nutrition orders at the patient’s bedside using an iPad or tablet. These orders are electronically transmitted to the APEX compounder, thereby helping to reduce manual programming errors, eliminate transcription errors, and expedite patient care. Attendees visiting B. Braun’s booth also will be able to receive a free personalized medical body composition analysis by INBODY. The analysis will assess individual body fat, body water, segmental muscle and energy requirements.
In addition, B. Braun offers a wide selection of amino acid formulations and related additives ─ in containers not made with natural rubber latex, PVC or DEHP to help clinicians provide safe, appropriate nutritional support for patients’ individualized needs. B. Braun was the first medical device manufacturer to remove harmful PVC and DEHP from many of its products. To learn more about B. Braun’s commitment to protecting people and the environment while improving patient outcomes and reducing healthcare costs visit www.bbrauncares.com.
Another integral part of PN360 is Central Admixture Pharmacy Services, Inc. (CAPS®), a B. Braun company — the nation’s largest network of outsourcing admixture pharmacies and a leader in customized parenteral nutrition. Pharmacy Systems Specialists will be at the booth to discuss B. Braun’s customized parenteral nutrition compounding offering, including local, same-day delivery with easy online ordering through CAPS.
Additionally, B. Braun representatives will demonstrate how the company’s robust portfolio of pharmaceutical and drug delivery products can help improve patient care through its:
- PharmView application, DoseTrac® infusion management software and its 2nd generation, large-volume Infusomat® Space Pump, including its AutoCOMPLETE™ Integrated EMR functions (AutoProgramming, AutoDocumentation and AutoNotification).
- OnGuard® CSTD, a closed system transfer device (CSTD) designed to protect healthcare workers from accidental exposure to hazardous drugs.
- DUPLEX® container. B. Braun’s latest drug delivery portfolio expansion that allows patients to receive intravenous antibiotic therapies such as Meropenem via its DUPLEX container. The DUPLEX container can save time, labor, and speeds dispensing because it can be stored in an automated dispensing cabinet in healthcare settings.
In addition, B. Braun also will feature www.ReadyFor800.com. The company’s latest online educational resource will focus on the awareness and implementation of the new hazardous drug safety standard, USP <800>.
“These medications can save the lives of patients, but they also pose risk to our healthcare professionals,” said Sutton. “As one of the leading suppliers of CSTDs in the United States, B. Braun takes great pride in helping nurses and other healthcare workers proactively protect not only their patients, but also themselves and their coworkers.”
About B. Braun
B. Braun Medical Inc., a leader in infusion therapy and pain management, develops, manufactures, and markets innovative medical products and services to the healthcare industry. The company is committed to eliminating preventable treatment errors and enhancing patient, clinician and environmental safety. B. Braun Medical is headquartered in Bethlehem, Pa., and is part of the B. Braun Group of Companies in the U.S., which includes B. Braun Interventional Systems, Aesculap® and CAPS®.
Globally, the B. Braun Group of Companies employs more than 58,000 employees in 64 countries. Guided by its Sharing Expertise® philosophy, B. Braun continuously exchanges knowledge with customers, partners and clinicians to address the critical issues of improving care and lowering costs. To learn more about B. Braun Medical, visit www.BBraunUSA.com.
Contact: Jason Ford
B. Braun Medical Inc.
610.997.4722
jason.ford@bbraun.com